Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 1
1960 2
1962 1
1963 2
1964 1
1965 2
1967 2
1968 1
1969 3
1970 3
1971 2
1972 4
1973 2
1974 7
1975 3
1976 5
1977 5
1978 11
1979 23
1980 28
1981 15
1982 33
1983 26
1984 37
1985 40
1986 43
1987 27
1988 11
1989 15
1990 10
1991 8
1992 8
1993 8
1994 5
1995 12
1996 7
1997 13
1998 7
1999 20
2000 24
2001 28
2002 29
2003 17
2004 20
2005 21
2006 14
2007 18
2008 21
2009 24
2010 24
2011 36
2012 34
2013 43
2014 28
2015 42
2016 43
2017 49
2018 44
2019 42
2020 47
2021 45
2022 52
2023 48
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

1,173 results

Results by year

Filters applied: . Clear all
Page 1
Transcription factor EGR2 controls homing and pathogenicity of TH17 cells in the central nervous system.
Gao Y, Wang Y, Chauss D, Villarino AV, Link VM, Nagashima H, Spinner CA, Koparde VN, Bouladoux N, Abers MS, Break TJ, Chopp LB, Park JH, Zhu J, Wiest DL, Leonard WJ, Lionakis MS, O'Shea JJ, Afzali B, Belkaid Y, Lazarevic V. Gao Y, et al. Among authors: nagashima h. Nat Immunol. 2023 Aug;24(8):1331-1344. doi: 10.1038/s41590-023-01553-7. Epub 2023 Jul 13. Nat Immunol. 2023. PMID: 37443284 Free PMC article.
Bevacizumab plus erlotinib versus erlotinib alone in Japanese patients with advanced, metastatic, EGFR-mutant non-small-cell lung cancer (NEJ026): overall survival analysis of an open-label, randomised, multicentre, phase 3 trial.
Kawashima Y, Fukuhara T, Saito H, Furuya N, Watanabe K, Sugawara S, Iwasawa S, Tsunezuka Y, Yamaguchi O, Okada M, Yoshimori K, Nakachi I, Seike M, Azuma K, Kurimoto F, Tsubata Y, Fujita Y, Nagashima H, Asai G, Watanabe S, Miyazaki M, Hagiwara K, Nukiwa T, Morita S, Kobayashi K, Maemondo M. Kawashima Y, et al. Among authors: nagashima h. Lancet Respir Med. 2022 Jan;10(1):72-82. doi: 10.1016/S2213-2600(21)00166-1. Epub 2021 Aug 26. Lancet Respir Med. 2022. PMID: 34454653 Clinical Trial.
Carbohydrate antigens.
Miyagawa S, Ueno T, Nagashima H, Takama Y, Fukuzawa M. Miyagawa S, et al. Among authors: nagashima h. Curr Opin Organ Transplant. 2012 Apr;17(2):174-9. doi: 10.1097/MOT.0b013e3283508189. Curr Opin Organ Transplant. 2012. PMID: 22262104 Review.
Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-squamous non-small-cell lung cancer (NEJ026): interim analysis of an open-label, randomised, multicentre, phase 3 trial.
Saito H, Fukuhara T, Furuya N, Watanabe K, Sugawara S, Iwasawa S, Tsunezuka Y, Yamaguchi O, Okada M, Yoshimori K, Nakachi I, Gemma A, Azuma K, Kurimoto F, Tsubata Y, Fujita Y, Nagashima H, Asai G, Watanabe S, Miyazaki M, Hagiwara K, Nukiwa T, Morita S, Kobayashi K, Maemondo M. Saito H, et al. Among authors: nagashima h. Lancet Oncol. 2019 May;20(5):625-635. doi: 10.1016/S1470-2045(19)30035-X. Epub 2019 Apr 8. Lancet Oncol. 2019. PMID: 30975627 Clinical Trial.
The Innate Cellular Immune Response in Xenotransplantation.
Maeda A, Kogata S, Toyama C, Lo PC, Okamatsu C, Yamamoto R, Masahata K, Kamiyama M, Eguchi H, Watanabe M, Nagashima H, Okuyama H, Miyagawa S. Maeda A, et al. Among authors: nagashima h. Front Immunol. 2022 Mar 28;13:858604. doi: 10.3389/fimmu.2022.858604. eCollection 2022. Front Immunol. 2022. PMID: 35418992 Free PMC article. Review.
Diagnosis and management of spinal infections.
Nagashima H, Tanishima S, Tanida A. Nagashima H, et al. J Orthop Sci. 2018 Jan;23(1):8-13. doi: 10.1016/j.jos.2017.09.016. Epub 2017 Oct 20. J Orthop Sci. 2018. PMID: 29066036 Free article. Review.
Genome Editing of Pig.
Watanabe M, Nagashima H. Watanabe M, et al. Among authors: nagashima h. Methods Mol Biol. 2023;2637:269-292. doi: 10.1007/978-1-0716-3016-7_21. Methods Mol Biol. 2023. PMID: 36773154
Chondrocranial variation in chicken domestication.
Núñez-León D, Nagashima H, Sánchez-Villagra MR. Núñez-León D, et al. Among authors: nagashima h. J Exp Zool B Mol Dev Evol. 2022 Dec;338(8):505-515. doi: 10.1002/jez.b.23177. Epub 2022 Oct 3. J Exp Zool B Mol Dev Evol. 2022. PMID: 36189911
A Strategy for Suppressing Macrophage-mediated Rejection in Xenotransplantation.
Maeda A, Lo PC, Sakai R, Noguchi Y, Kodama T, Yoneyama T, Toyama C, Wang HT, Esquivel E, Jiaravuthisan P, Choi TV, Takakura C, Eguchi H, Tazuke Y, Watanabe M, Nagashima H, Okuyama H, Miyagawa S. Maeda A, et al. Among authors: nagashima h. Transplantation. 2020 Apr;104(4):675-681. doi: 10.1097/TP.0000000000003024. Transplantation. 2020. PMID: 31634326 Review.
1,173 results